Sign in
4

Changes in Ownership

Maze Therapeutics, Inc. Filed Acc 0001192591-25-000010

Director acquired 1,489 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HOMCY CHARLES J Director 2025-11-19 Other acquisition +1,489 31,113 D: show line 1 in the form
Loading xslF345X05/form4-11212025_091144.xml…